Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 618

1.

Treatment of colorectal cancer in older patients. International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.

Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Köhne CH, Rostoft S, Lemmens V, Mitry E, Rutten H, Sargent D, Sastre J, Seymour M, Starling N, Van Cutsem E, Aapro M.

Ann Oncol. 2014 Jul 11. pii: mdu253. [Epub ahead of print] Review.

PMID:
25015334
[PubMed - as supplied by publisher]
2.

FcγRIIa and FcγRIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease.

Sclafani F, Gonzalez de Castro D, Cunningham D, Hulkki-Wilson S, Peckitt C, Capdevila J, Glimelius B, Rosello Keranen S, Wotherspoon A, Brown G, Tait D, Begum R, Thomas J, Oates J, Chau I.

Clin Cancer Res. 2014 Jul 1. pii: clincanres.0674.2014. [Epub ahead of print]

PMID:
24987061
[PubMed - as supplied by publisher]
3.

TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial.

Sclafani F, Gonzalez D, Cunningham D, Hulkki Wilson S, Peckitt C, Tabernero J, Glimelius B, Cervantes A, Dewdney A, Wotherspoon A, Brown G, Tait D, Oates J, Chau I.

J Natl Cancer Inst. 2014 Jun 23;106(7). pii: dju121. doi: 10.1093/jnci/dju121. Print 2014 Jul.

PMID:
24957073
[PubMed - in process]
4.

Acta Oncologica and a new generation of scientists in oncology.

Glimelius B, Johansen C, Muren LP, Nilbert M.

Acta Oncol. 2014 Jul;53(7):849-51. doi: 10.3109/0284186X.2014.913102. No abstract available.

PMID:
24954366
[PubMed - in process]
5.

Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, Foss A, Tveit KM.

Ann Surg. 2014 Jun 19. [Epub ahead of print]

PMID:
24950280
[PubMed - as supplied by publisher]
6.

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, Mack TM, Ghesquieres H, Hwang AE, Nieters A, de Sanjose S, Lightfoot T, Becker N, Maynadie M, Foretova L, Roman E, Benavente Y, Rand KA, Nathwani BN, Glimelius B, Staines A, Boffetta P, Link BK, Kiemeney L, Ansell SM, Bhatia S, Strong LC, Galan P, Vatten L, Habermann TM, Duell EJ, Lake A, Veenstra RN, Visser L, Liu Y, Urayama KY, Montgomery D, Gaborieau V, Weiss LM, Byrnes G, Lathrop M, Cocco P, Best T, Skol AD, Adami HO, Melbye M, Cerhan JR, Gallagher A, Taylor GM, Slager SL, Brennan P, Coetzee GA, Conti DV, Onel K, Jarrett RF, Hjalgrim H, van den Berg A, McKay JD.

Nat Commun. 2014 Jun 12;5:3856. doi: 10.1038/ncomms4856.

PMID:
24920014
[PubMed - in process]
7.

Adjuvant chemotherapy for rectal cancer.

Bujko K, Glimelius B.

Lancet Oncol. 2014 May;15(6):e194-5. doi: 10.1016/S1470-2045(14)70071-3. No abstract available.

PMID:
24807860
[PubMed - indexed for MEDLINE]
8.

Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?

Glimelius B.

Front Oncol. 2014 Apr 7;4:50. doi: 10.3389/fonc.2014.00050. eCollection 2014. Review.

PMID:
24778990
[PubMed]
Free PMC Article
9.

Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M.

PLoS One. 2014 Apr 23;9(4):e94621. doi: 10.1371/journal.pone.0094621. eCollection 2014.

PMID:
24760019
[PubMed - in process]
Free PMC Article
10.

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.

Dias MM, Pignon JP, Karapetis CS, Boige V, Glimelius B, Kweekel DM, Lara PN, Laurent-Puig P, Martinez-Balibrea E, Páez D, Punt CJ, Redman MW, Toffoli G, Wadelius M, McKinnon RA, Sorich MJ.

Pharmacogenomics J. 2014 Apr 8. doi: 10.1038/tpj.2014.16. [Epub ahead of print]

PMID:
24709690
[PubMed - as supplied by publisher]
11.

Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin).

Gubanski M, Glimelius B, Lind PA.

Med Oncol. 2014 Apr;31(4):906. doi: 10.1007/s12032-014-0906-7. Epub 2014 Mar 14.

PMID:
24627237
[PubMed - in process]
12.

Clinical benefit response in pancreatic cancer trials revisited.

Bernhard J, Dietrich D, Glimelius B, Bodoky G, Scheithauer W, Herrmann R.

Oncol Res Treat. 2014;37(1-2):42-8. doi: 10.1159/000357965. Epub 2014 Jan 20.

PMID:
24613908
[PubMed - in process]
Free Article
13.

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent D, Green E, McLeod H, Zanger UM, Schwab M, Braun M, Seymour M, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Jensen SA, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig P, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley R, Kerr D, Tomlinson I.

J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857. Epub 2014 Mar 3. Review.

PMID:
24590654
[PubMed - indexed for MEDLINE]
14.

RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial.

Sclafani F, Gonzalez D, Cunningham D, Hulkki Wilson S, Peckitt C, Giralt J, Glimelius B, Roselló Keränen S, Wotherspoon A, Brown G, Tait D, Oates J, Chau I.

Eur J Cancer. 2014 May;50(8):1430-6. doi: 10.1016/j.ejca.2014.02.002. Epub 2014 Feb 28.

PMID:
24582914
[PubMed - indexed for MEDLINE]
15.

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.

Tarpgaard LS, Guren TK, Glimelius B, Christensen IJ, Pfeiffer P, Kure EH, Sorbye H, Ikdahl T, Yilmaz M, Johansen JS, Tveit KM.

PLoS One. 2014 Feb 3;9(2):e87746. doi: 10.1371/journal.pone.0087746. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e98836.

PMID:
24498368
[PubMed - in process]
Free PMC Article
16.

Adjuvant chemotherapy for rectal cancer still controversial.

Beets GL, Glimelius BL.

Lancet Oncol. 2014 Feb;15(2):130-1. doi: 10.1016/S1470-2045(14)70016-6. Epub 2014 Jan 17. No abstract available.

PMID:
24440476
[PubMed - indexed for MEDLINE]
17.

Neo-adjuvant radiotherapy in rectal cancer.

Glimelius B.

World J Gastroenterol. 2013 Dec 14;19(46):8489-501. doi: 10.3748/wjg.v19.i46.8489. Review.

PMID:
24379566
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The 50-year anniversary of Acta Oncologica.

Glimelius B.

Acta Oncol. 2014 Jan;53(1):1-2. doi: 10.3109/0284186X.2013.864051. No abstract available.

PMID:
24345297
[PubMed - in process]
19.

The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines.

Sahlberg SH, Gustafsson AS, Pendekanti PN, Glimelius B, Stenerlöw B.

Tumour Biol. 2014 Apr;35(4):3525-34. doi: 10.1007/s13277-013-1465-9. Epub 2013 Dec 14.

PMID:
24338765
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

Greenhalf W, Ghaneh P, Neoptolemos JP, Palmer DH, Cox TF, Lamb RF, Garner E, Campbell F, Mackey JR, Costello E, Moore MJ, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Shannon J, Dervenis C, Glimelius B, Deakin M, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Halloran CM, Mayerle J, Oláh A, Jackson R, Rawcliffe CL, Scarpa A, Bassi C, Büchler MW; European Study Group for Pancreatic Cancer.

J Natl Cancer Inst. 2014 Jan;106(1):djt347. doi: 10.1093/jnci/djt347. Epub 2013 Dec 3.

PMID:
24301456
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk